Actuate Therapeutics Funding: $28M Raised, IPO (2024)

Actuate Therapeutics is based in Grayslake, Illinois. It has raised $28M in total funding. Latest round: IPO.

Actuate Therapeutics funding overview

Actuate Therapeutics is based in Grayslake, Illinois. Actuate Therapeutics has raised $28M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is an IPO announced in January 2024. The round record for Actuate Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Kairos Ventures, Bios Partners, DEFTA Partners, Tech Coast Angels. 4 distinct backers are named across the disclosed rounds.

Actuate Therapeutics at a glance

Total raised
$28M
Latest round
IPO
Latest round date
January 2024
Headquarters
Grayslake, Illinois
Notable investors
Kairos Ventures, Bios Partners, DEFTA Partners, Tech Coast Angels

Frequently asked about Actuate Therapeutics funding

How much has Actuate Therapeutics raised?
Actuate Therapeutics has raised $28M in total disclosed funding across the rounds on record.
Who has invested in Actuate Therapeutics?
Kairos Ventures, Bios Partners, DEFTA Partners, Tech Coast Angels are named among the investors backing Actuate Therapeutics.
What was the latest Actuate Therapeutics funding round?
The most recent disclosed round is an IPO, announced in January 2024.
Where is Actuate Therapeutics based?
Actuate Therapeutics is based in Grayslake, Illinois.
When did Actuate Therapeutics last raise?
The last disclosed Actuate Therapeutics round closed in January 2024 at IPO.

Round data for Actuate Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Grayslake and backer lists below.

Companies related to Actuate Therapeutics (33)

Browse related funding lists (3)

Company funding database · Investor directory · Founder database · Mega-rounds 2026